Bermuda Recalls Multiple Semaglutide Injection Products Due to Quality and Packaging Issues

Bermudian health authorities have issued recalls for several Semaglutide injection products. The recalls are due to product impurities, incorrect dose displays, and packaging errors that could lead to patients receiving the wrong dosage. Semaglutide is a prescription medication used for blood glucose control and weight management, making accurate dosing critical for safe and effective treatment. Pharmacies and medical warehouses in Bermuda have been notified, and patients are advised to contact their pharmacist if they believe they have an affected product.